Sotio Biotech logo
VerifiedBiotechnology Research· Founded 2010

Sotio Biotech

SOTIO Biotech is shaping the future of cancer immunotherapies by translating compelling science into patient benefit. SOTIO’s robust clinical pipeline includes a next-generation PD-1-inhibiting cytokine, a proprietary technology designed to improve on the efficacy of CAR T therapies and a new generation of potent and stable antibody-drug conjugates (ADCs). SOTIO is a member of the PPF Group.

7-day free trial · no credit card

HeadquartersPrague 9, Czech RepublicEmployees203(201 to 500)Annual revenue$1M to <$10MFounded year2010Websitesotio.comLinkedIn profileLinkedIn

Verified contacts

176

available on Kipplo

LinkedIn employees

203

201 to 500 range

Open roles

no listings

Distinct roles

130

indexed titles

Tech stack

2

tools in use

Monthly traffic

284

organic / mo

Sign up free to see all 176 verified contacts at Sotio Biotech

Free for 7 days · 50 credits · no card · only pay for verified records.

Sign up free

Decision-makers and verified team members

176 contacts with verified email or phone · masked until revealed.

Sign up free →

Top roles at Sotio Biotech

130 distinct titles indexed · top 10 shown.

  • 15junior scientist
  • 9scientist
  • 6manufacturing associate
  • 6senior scientist
  • 3office manager
  • 3senior medical director early clinical development
  • 2business intelligence analyst
  • 2hr generalist
  • 2junior research scientist
  • 2microbiologist
  • +120more titles

Sign up to unlock all 176 contacts at Sotio Biotech

Free for 7 days · 50 credits · no card · only pay for verified records.

Sign up free

Sign up to reveal 176 verified contacts at Sotio Biotech

7-day trial · no credit card · cancel anytime · only pay for verified records.

Trusted by sales, marketing, and GTM engineering teams.

Sotio Biotech | Kipplo Discover